EMERGENT BIOSOLUTIONS Insider Sales: CEO’s 10b5‑1 Move Keeps Investors Calm as Stock Climbs 18.5% This Month
Insider sales at EMERGENT BIOSOLUTIONS are routine tax‑planning moves—no distress signals, just modest 10b5‑1 trades as the stock climbs on a strong pipeline.
3 minutes to read